Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
GreyBird Ventures, LLC is a venture capital firm founded in 2016 by Tom Miller, Michael Devlin, and Scott Gazelle, based in the United States. The firm focuses on early-stage investments in healthcare and biotech, specifically targeting companies that address significant diagnostic challenges in precision medicine. GreyBird currently manages a portfolio of 8 companies.
GreyBird Ventures specializes in investing in early-stage companies that develop innovative diagnostic technologies aimed at enhancing precision medicine. The firm invests in pre-seed to Series A stages, with a particular emphasis on solutions that improve healthcare efficiency and patient care by eliminating trial and error in medical diagnostics.
Notable portfolio companies include Angstrom Bio, Platomics, GNA Biosolutions, JF Healthcare, NeuroKaire (formerly Genetika+), Atlas5D, Hummingbird Diagnostics, and Ceres Nano. These companies are advancing technologies that enhance precision medicine.
Email your pitch deck to greybird@greybirdventures.com for consideration.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.